Gaseous signaling molecules

Flexjet to Achieve Emissions-Neutral Flight Operations in Europe via 4AIR Partnership

Retrieved on: 
Monday, May 17, 2021
Consumer, Manufacturing, Other Energy, Retail, Oil, Gas, Other Travel, Energy, Finance, Consulting, Travel, Banking, Science, Other Transport, Professional services, Luxury, Other Consumer, Air, Transport, Women, Other Science, Other Manufacturing, MEN, Chemical compounds, Chemistry, Physical sciences, Gaseous signaling molecules, Greenhouse gases, Flexjet, Carbon dioxide, Nitrous oxide, Flexjet, the 4AIR Rating Program, 4AIR, FLEXJET, THE 4AIR RATING PROGRAM, 4AIR

View the full release here: https://www.businesswire.com/news/home/20210517005281/en/\nLeading private jet shared ownership provider Flexjet has unveiled details of a new sustainability programme for its European operation, which includes a 300% carbon dioxide equivalent offset made for every flight.

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20210517005281/en/\nLeading private jet shared ownership provider Flexjet has unveiled details of a new sustainability programme for its European operation, which includes a 300% carbon dioxide equivalent offset made for every flight.
  • Working with 4AIR, Flexjet offsets 300% of the carbon dioxide equivalent for every flight, to reflect both CO2 emissions and other pollutants, including water vapor, aerosol sulphate and nitrous oxides.
  • In 2015, Flexjet introduced Red Label by Flexjet, which features the youngest fleet in the industry, flight crews dedicated to a single aircraft and the LXi Cabin Collection of interiors.
  • 4AIR also serves the demand signal working groups with the World Economic Forum\xe2\x80\x99s Clean Skies for Tomorrow Coalition .\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210517005281/en/\n'

“The Methanol Pathway to Hydrogen” Webinar

Retrieved on: 
Wednesday, May 12, 2021
Automotive Manufacturing, Travel, Manufacturing, Oil, Gas, Alternative Vehicles, Fuels, Automotive, Trucking, Alternative energy, Rail, Energy, Maritime, Transport, Environment, Cruise, Energy, Chemistry, Physical sciences, Hydrogen economy, Energy storage, Hydrogen technologies, Gaseous signaling molecules, Industrial gases, Hydrogen production, Methanol, Fuel cell, Hydrogen vehicle

b'Element 1 Corp., (e1), a leading developer of hydrogen generation technology supporting clean fuel cell power technology, and the Methanol Institute (MI) are jointly organizing a webinar entitled \xe2\x80\x9cThe Methanol Pathway to Hydrogen\xe2\x80\x9d to be held on May 26, 2021, 8.00 a.m. (PDT).

Key Points: 
  • b'Element 1 Corp., (e1), a leading developer of hydrogen generation technology supporting clean fuel cell power technology, and the Methanol Institute (MI) are jointly organizing a webinar entitled \xe2\x80\x9cThe Methanol Pathway to Hydrogen\xe2\x80\x9d to be held on May 26, 2021, 8.00 a.m. (PDT).
  • The webinar will feature presenters who will discuss methanol\xe2\x80\x99s role as a superior hydrogen carrier supporting the global transition towards cleaner fuels.
  • The lack of efficient storage and transport methods is one of the most significant obstacles to overcome before hydrogen can be widely adopted as an energy product.\nGenerators that produce hydrogen from methanol can deliver on-demand hydrogen at the point of use, eliminating the need to transport compressed hydrogen gas.
  • In addition, this process can be carbon-neutral, and in some cases carbon-negative, when methanol is produced from renewable feedstocks such as captured carbon dioxide or municipal solid waste.\nFor more information about how methanol offers a pathway to hydrogen utilization, register for the webinar here .\nThe Methanol Institute (MI) serves as the global trade association for the methanol industry, representing the world\xe2\x80\x99s leading producers, distributors, and technology companies.

Claritas Pharmaceuticals Issues Letter to Shareholders

Retrieved on: 
Tuesday, May 11, 2021
Chemistry, Physical sciences, Natural sciences, GABAA receptor positive allosteric modulators, Oxides, Gaseous signaling molecules, Nitrogen cycle, Orphan drugs, Nitric oxide, Lead(II,IV) oxide, Nitric oxide, Lanthanum

Through its Australian subsidiary, Claritas applied for refunds for R&D expenses incurred in 2018 and 2019.

Key Points: 
  • Through its Australian subsidiary, Claritas applied for refunds for R&D expenses incurred in 2018 and 2019.
  • In July and September 2020, Claritas received R&D refunds of AUD $1,376,000 and AUD $1,817,000, respectively.
  • We have brought together a team of internationally renowned experts in nitric oxide science, and our goal is to position the Company as the leader in nitric oxide pharmaceuticals.
  • Our goal for 2021 is to complete our Phase 1 study in Australia demonstrating that R-107 is safe in humans.

Fusion Fuel Green PLC Announces Partnership with CCC to Develop Green Hydrogen Demonstrator Plant in Middle East

Retrieved on: 
Thursday, May 6, 2021
Chemistry, Physical sciences, Natural sciences, Industrial gases, Hydrogen economy, Gaseous signaling molecules, Refrigerants, Emerging technologies, Hydrogen vehicle, Fuel, Ammonia, Hydrogen

b'DUBLIN, Ireland, May 06, 2021 (GLOBE NEWSWIRE) -- Fusion Fuel Green PLC (NASDAQ: HTOO), ("Fusion Fuel", or "the Company"), a green hydrogen technology company, is pleased to announce that it reached a collaboration agreement with Consolidated Contractors Group S.A.L.

Key Points: 
  • b'DUBLIN, Ireland, May 06, 2021 (GLOBE NEWSWIRE) -- Fusion Fuel Green PLC (NASDAQ: HTOO), ("Fusion Fuel", or "the Company"), a green hydrogen technology company, is pleased to announce that it reached a collaboration agreement with Consolidated Contractors Group S.A.L.
  • (Offshore) (\xe2\x80\x9cCCC\xe2\x80\x9d), to develop green hydrogen plants in the Middle East.\nCCC and Fusion Fuel have agreed to cooperate on projects involving the production of green hydrogen for potential clients in the refining and petrochemical industries in order to reduce their carbon footprint.
  • We are excited to bring Fusion Fuel\'s revolutionary technology to the Middle East.\xe2\x80\x9d\nDori Barakat, Director of Business Development at CCC added: \xe2\x80\x9cWe are very pleased to cooperate with Fusion Fuel towards the building of Green Hydrogen and Ammonia plants and to bring our expertise in construction projects, particularly in the Middle East.
  • It is committed to responsible growth, serving local communities and society, and respecting the environment.\nAbout Fusion Fuel Green plc.\nFusion Fuel Green plc.

Mallinckrodt Presents Data Evaluating INOmax® (Nitric Oxide) Gas, for Inhalation in a Phase 4 Observational Registry in Neonates with Pulmonary Hypertension at the Pediatric Academic Societies (PAS) 2021 Virtual Meeting

Retrieved on: 
Friday, April 30, 2021
Branches of biology, Nitrogen cycle, Gaseous signaling molecules, Physical sciences, Chemistry, GABAA receptor positive allosteric modulators, NMDA receptor antagonists, Biological functions of nitric oxide, Inferiority complex, Nitric oxide, Methemoglobinemia

A total of 50 (90.9 percent) PT and 75 (88.2 percent) TNT neonates achieved a 25 percent decrease in OI/SOI during treatment with INOmax.

Key Points: 
  • A total of 50 (90.9 percent) PT and 75 (88.2 percent) TNT neonates achieved a 25 percent decrease in OI/SOI during treatment with INOmax.
  • Efficacy in the PT group demonstrated non-inferiority (95 percent confidence interval: 0.0267 [-0.0333, 0.0868], with a pre-defined margin of -0.1452).
  • Hence, some of the improvement observed in the study could be due to factors other than treatment with INOmax.
  • Nitric oxide donor compounds may have an additive effect with INOmax on the risk of developing methemoglobinemia.

Worldwide Nitric Oxide Industry to 2030 - Concepts of NO in Health and Disease as a Basis for Therapeutics and Development of New Drugs

Retrieved on: 
Monday, April 26, 2021
Branches of biology, Chemistry, Physical sciences, Gaseous signaling molecules, Nitrogen cycle, Nitric oxide, Oxides, Nitric oxide, Biological functions of nitric oxide

b'DUBLIN, April 26, 2021 /PRNewswire/ -- The "Nitric Oxide - Therapeutics, Markets and Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com\'s offering.\nThis report describes the latest concepts of the role of nitric oxide (NO) in health and disease as a basis for therapeutics and development of new drugs.

Key Points: 
  • b'DUBLIN, April 26, 2021 /PRNewswire/ -- The "Nitric Oxide - Therapeutics, Markets and Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com\'s offering.\nThis report describes the latest concepts of the role of nitric oxide (NO) in health and disease as a basis for therapeutics and development of new drugs.
  • It also functions as a signaling molecule and has an important role in the pathogenesis of several diseases.
  • Another approach is modulation of nitric oxide synthase (NOS), which converts L-arginine to NO.
  • The report includes profiles of 36 companies involved in this area of which 10 have a significant interest in NO-based therapeutics.

The Worldwide Inhaled Nitric Oxide Industry is Expected to Reach $915.7 Million by 2026

Retrieved on: 
Tuesday, April 20, 2021
Branches of biology, Biology, Gaseous signaling molecules, Nitrogen cycle, Hypertension, Respiratory physiology, Pulmonary hypertension, Hemoglobin, Nitric oxide, Blood, Red blood cell, Biological functions of nitric oxide

Nitric oxide is a molecule of gas that causes a sense of relaxation in smooth muscle cells in the vasculature.

Key Points: 
  • Nitric oxide is a molecule of gas that causes a sense of relaxation in smooth muscle cells in the vasculature.
  • The gas is quickly collected by oxyhemoglobin in red blood cells and the vasodilating effects caused by inhaled nitric oxide are restricted to oxygenated areas of the lungs.
  • Hence, the inhaled nitric oxide is utilized to cure various cardiopulmonary conditions, like pulmonary hypertension in adults and children.
  • North America emerged as the leading region in the global inhaled nitric oxide market in 2019.

Global Hydrogen Market Report 2020-2030:Opportunities in Producing Hydrogen by Using Environment-friendly Process & Increasing Number of Mergers and Acquisitions

Retrieved on: 
Wednesday, April 14, 2021
Chemistry, Physical sciences, Natural sciences, Industrial gases, Gaseous signaling molecules, Refrigerants, Sustainable technologies, Emerging technologies, Hydrogen production, Hydrogen, Ammonia, Hydrogen economy

The low supply of natural gas has led to the lower production of hydrogen.

Key Points: 
  • The low supply of natural gas has led to the lower production of hydrogen.
  • Via this process, hydrogen can be produced cost-effectively, and the feedstock used during it is also readily available.
  • This method is less complex and also cost-effective in the long run, compared to the tanker and cylinder methods of hydrogen transportation.
  • Hydrogen finds high-volume application in the production of methanol and ammonia, the latter of which is itself used in the production of fertilizers.

New Publication Analyzes Interhospital Transport of Newborns Using VERO Biotech's GENOSYL® Delivery System for the Delivery of Inhaled Nitric Oxide

Retrieved on: 
Friday, April 16, 2021
Gaseous signaling molecules, Nitrogen cycle, Respiratory therapy

b'ATLANTA, April 16, 2021 /PRNewswire/ --GENOSYL Delivery System, a novel tankless, cassette-based delivery system for Inhaled Nitric Oxide, can greatly facilitate the delivery of iNO during interhospital transport of newborns, according to a new publication in the Spring 2021 issue of the journal RT Magazine.

Key Points: 
  • b'ATLANTA, April 16, 2021 /PRNewswire/ --GENOSYL Delivery System, a novel tankless, cassette-based delivery system for Inhaled Nitric Oxide, can greatly facilitate the delivery of iNO during interhospital transport of newborns, according to a new publication in the Spring 2021 issue of the journal RT Magazine.
  • Therefore, the standard of care is to transport such patients while continuing iNO treatment.\nMoreover, while there are alternative iNO delivery systems available for transport, the authors point out that only GENOSYL Delivery System has been approved by the U.S. Food and Drug Administration (FDA) for the administration of inhaled Nitric Oxide during interhospital patient transport.
  • "\nFurthermore, the publication authors reassert the value of "on-label" use of a drug or device, primarily with respect to patient safety.
  • Third, it offers consistent information on any monitoring that should be applied when the patient is using the device or drug.

Global Hydrogen Market Research Report 2020-2030: Production Process, Distribution Method, End User - ResearchAndMarkets.com

Retrieved on: 
Friday, April 9, 2021
Chemicals, Plastics, Manufacturing, Chemistry, Physical sciences, Industrial gases, Natural sciences, Gaseous signaling molecules, Hydrogen production, Emerging technologies, Hydrogen technologies, Hydrogen vehicle, Methane, Hydrogen, Hydrogen economy

The "Hydrogen Market Research Report: By Production Process, Distribution Method, End User - Global Industry Outlook and Growth Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Hydrogen Market Research Report: By Production Process, Distribution Method, End User - Global Industry Outlook and Growth Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.
  • Global hydrogen market to reach $196,934.5 million by 2030 from $136,185.0 million in 2019, at a 4.3% CAGR between 2020 and 2030.
  • The steam-methane reforming category is predicted to continue holding the largest share in the hydrogen market in the coming years, based on production process.
  • The chemical category dominated the hydrogen market in the past, based on end user.